
PaySign Inc (PAYS) Stock Forecast & Price Target
PaySign Inc (PAYS) Analyst Ratings
Bulls say
PaySign Inc. is forecasted to achieve a remarkable 26% year-over-year revenue growth, reaching $73.4 million in 2025, indicating strong demand for its prepaid card programs and integrated payment solutions. Furthermore, adjusted EBITDA is expected to grow by 72% year-over-year, resulting in $16.6 million with the accompanying margins anticipated to expand significantly by 610 basis points to 22.6%. The company’s first-quarter performance also reflects this positive trajectory, showcasing a 193% year-over-year increase in adjusted EBITDA to $5.0 million, surpassing forecasts by 14%.
Bears say
PaySign Inc. has reported a significant decline in revenue within its Plasma Donor Compensation segment, with a year-over-year fall of 9% to $9.4 million, which was also 5% below the company's forecast. This downturn is attributed to an oversupply of plasma in the U.S., driven by new extraction techniques that have led to lower donor compensation. Additionally, the company experienced a severe revenue drop of 30% in 2020 compared to the previous year, resulting in adjusted EBITDA turning negative at a loss of $2.8 million, highlighting ongoing operational challenges.
This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.
PaySign Inc (PAYS) Analyst Forecast & Price Prediction
Start investing in PaySign Inc (PAYS)
Order type
Buy in
Order amount
Est. shares
0 shares